Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kania Edwin M Jr
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   11,446,567    

Indirect Shares

  62,961,806      
Direct Value   $114,390,890    

Indirect Value

  $160,054,052      
Total Shares   74,408,373      
Total Value   $274,444,942      


Exact Sciences Corp
 $7,731,584 Tetraphase Pharmaceuticals Inc
 $275,125 Acceleron Pharma Inc
 $5,136,203 Carisma Therapeutics Inc
 $2,522,766 Concert Pharmaceuticals, Inc.
 $5,494,821 Selecta Biosciences Inc
 $13,373 Syros Pharmaceuticals, Inc.
 $12,202,541 Editas Medicine, Inc.
 $14,954,625 Quanterix Corp
 $31,492,977 Moderna, Inc.
 $0 Transmedics Group, Inc.
 $34,566,874 Exact Sciences Corp
 $7,731,584 Tetraphase Pharmaceuticals Inc
 $275,125 Acceleron Pharma Inc
 $5,136,203 Carisma Therapeutics Inc
 $2,522,766 Concert Pharmaceuticals, Inc.
 $5,494,821 Selecta Biosciences Inc
 $13,373 Syros Pharmaceuticals, Inc.
 $12,202,541 Editas Medicine, Inc.
 $14,954,625 Quanterix Corp
 $31,492,977 Moderna, Inc.
 $0 Transmedics Group, Inc.
 $34,566,874
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   115.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Exact Sciences Corp EXAS Director 2009-07-20 172,503 2009-07-20 1,202,787    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH 10% Owner 2013-03-25 1,165,786 2013-03-25 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2014-12-23 28,734 2014-12-23 544,055    Premium*  
            DNIB Upwind Inc BIND 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 2016-09-23 1,940,589 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2014-02-19 656,490 0    Premium*  
            T2 Biosystems, Inc. TTOO 10% Owner 2014-08-12 0 2014-08-12 2,374,571    Premium*  
            Bg Medicine, Inc. BGMD 10% Owner 2014-12-04 0 2014-12-11 4,915,402    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 0 2016-05-25 0    Premium*  
            Selecta Biosciences Inc SELB Director 2017-05-16 26,528 2017-05-16 560,067    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2017-08-17 2,378,663 2017-08-17 262,386    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-11 2,764,256 2016-08-11 45,422    Premium*  
            Quanterix Corp QTRX 10% Owner 2017-12-11 2,030,495 2017-12-11 0    Premium*  
            Evelo Biosciences Inc EVLO 10% Owner 2018-05-11 0 2018-05-11 18,233,403    Premium*  
            Rubius Therapeutics, Inc. RUBY 10% Owner 2018-07-20 0 2018-07-20 7,563,703    Premium*  
            Moderna, Inc. MRNA 10% Owner 2020-01-14 23,847 2019-12-11 20,253,972    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2019-03-04 2,682,840    Premium*  
            Transmedics Group, Inc. TMDX 2024-05-23 258,676 2024-05-23 46,142    Premium*  
            Axcella Health Inc. AXLA 10% Owner 0 2019-05-08 2,714,440    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
EXAS Exact Sciences Corp Director   –       •      –    2005-10-26 4 A $2.08 $9,999 D/D 4,807 82,036 -
EXAS Exact Sciences Corp Director   –       •      –    2006-07-21 4 A $2.09 $9,999 D/D 4,784 86,820 -
EXAS Exact Sciences Corp Director   –       •      –    2007-08-10 4 A $3.00 $30,000 D/D 10,000 96,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2008-07-18 4 A $0.71 $7,100 D/D 10,000 106,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-01-02 4 A $0.00 $0 D/D 60,344 167,164 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-07-20 4 A $0.00 $0 D/D 5,339 172,503 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2013-09-18 3 IO $0.00 $0 D/D 0 4,867 -
XLRN Acceleron Pharma Inc Director   –       •      –    2013-09-24 4 A $0.00 $0 I/I 2,276,479 2,281,346 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-04-22 4 AS $35.89 $4,367,167 I/I (121,682) 122,823 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-04-23 4 AS $33.81 $801,297 I/I (23,700) 121,472 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-04-24 4 AS $31.45 $26,877,736 I/I (854,618) 72,759 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-05-05 4 S $42.86 $9,220,986 I/I (215,142) 60,496 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-12-12 4 A $0.00 $0 D/D 23,867 28,734 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-12-12 4 D $0.00 $0 I/I (597,920) 251 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-12-12 4 A $0.00 $0 I/I 104,740 13,136 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-12-23 4 S $38.00 $2,065,300 I/I (54,350) 0 0 -
SELB Selecta Biosciences Inc Director   –       •       •   2016-06-21 3 IO $0.00 $0 I/I 0 31,115 -
SELB Selecta Biosciences Inc Director   –       •      –    2016-06-27 4 A $0.00 $0 I/I 1,620,747 1,651,862 0 -
SELB Selecta Biosciences Inc Director   –       •      –    2017-05-16 4 S $14.00 $3,735,130 I/I (266,795) 560,067 0 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-01 3 IO $0.00 $0 I/I 0 370,831 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-06 4 D $0.00 $0 I/I (1,297,907) 0 0 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-06 4 A $0.00 $0 I/I 370,831 7,511 0 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-06 4 A $0.00 $0 I/I 881,118 57,142 0 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-06 4 B $16.00 $533,328 D/D 33,333 33,333 2.39 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-10-29 4 A $0.00 $0 D/D 120,595 153,928 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed